지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Purpose: To predict the prognosis of hepatocellular carcinoma (HCC) patients who underwent transarterial chemoembolization (TACE). Materials and Methods: The study unvestigated the one- and two-year survival rates of 211patients who were divided into two groups : 74 operable Child's grade A or B cases, and 137 inoperable cases involving Child's grade C or poor prognostic factors such as metastasis, main portal thrombus, and total bilirubin above 2.0mg/dl. Cumulative survival curves were obtained by the Kaplan-Meier method, beginning with the day of the first TACE. Results: The one- and two-year cummulative survival rates were 80.8% and 47.9% for the 74 operable cases and 37.6% and 14.0% for the 137 inoperable cases, respectively(p<0.01). Conclusion: The prognosis of HCC patients who underwent TACE can be predicted by classifying then into two groups, operable or inoperable cases.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology
2010 .01
-
절제 가능한 간세포암에서 수술 전 경동맥화학색전술의 효과
대한내과학회지
2005 .01
-
간문맥혈전을 동반한 간암의 화학색전술 후 장기생존 1예
대한내과학회지
2009 .01
-
The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Clinical and Molecular Hepatology
2017 .01
-
간세포암 환자에서 간이식 후 조기재발에 대한 결과와 위험인자 및 간이식 전 간동맥 화학 색전술의 간이식 후 성적에 미치는 효과
Annals of Surgical Treatment and Research
2007 .05
-
Efficacy of Transarterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Prospective Study on the Survival of HCC Patients Treated with Transcatheter Arterial Lipiodol Chemoembolization
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Transarterial chemoembolization versus resection for the intermediate stage hepatocellular carcinoma
Clinical and Molecular Hepatology
2016 .01
-
간세포암 치료에서 수술 전 간동맥 화학색전술의 효과
대한내과학회지
2006 .01
-
Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
간암절제술후 재발한 간암의 간동맥 화학색전술
대한방사선의학회지
1991 .01
-
Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation
Annals of Surgical Treatment and Research
2018 .08
-
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Clinical and Molecular Hepatology
2020 .01
-
Polymorphisms in Genes of the De Novo Lipogenesis Pathway and Overall Survival of Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
Annals of Surgical Treatment and Research
2019 .06
-
Conventional versus Doxorubicin-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: a Tertiary Medical Centre Experience in Malaysia
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
간세포암의 화학색전요법:장기생존율과 예후인자
대한방사선의학회지
1996 .01
-
한국인 간세포암종 환자에서 간동맥화학색전술후 6개월 미만 조기 사망 군과 24개월 이상 장기 생존 군간의 비교
Clinical and Molecular Hepatology
2002 .01
-
간문맥 침윤이 있는 간세포암의 경간동맥 화학색전요법
대한방사선의학회지
1993 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0